<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">SEPTIN2 Protein</th></tr>
<tr><td><b>Gene</b></td><td>[SEPTIN2](/genes/septin2)</td></tr>
<tr><td><b>Protein Name</b></td><td>Septin-2</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q15021](https://www.uniprot.org/uniprot/Q15021)</td></tr>
<tr><td><b>Molecular Weight</b></td><td>41.5 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Cytoskeleton, plasma membrane, axon initial segment</td></tr>
<tr><td><b>Protein Family</b></td><td>Septin GTPase family</td></tr>
<tr><td><b>PDB Structures</b></td><td>2QK9, 4LYG, 5C2D</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">5 edges</a></td>
</tr>
</table>
</div>
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">SEPTIN2 Protein</th></tr>
<tr><td><b>Gene</b></td><td>[SEPTIN2](/genes/septin2)</td></tr>
<tr><td><b>Protein Name</b></td><td>Septin-2</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q15021](https://www.uniprot.org/uniprot/Q15021)</td></tr>
<tr><td><b>Molecular Weight</b></td><td>41.5 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Cytoskeleton, plasma membrane, axon initial segment</td></tr>
<tr><td><b>Protein Family</b></td><td>Septin GTPase family</td></tr>
<tr><td><b>PDB Structures</b></td><td>2QK9, 4LYG, 5C2D</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">5 edges</a></td>
</tr>
</table>
</div>
SEPTIN2 (Septin-2) is a member of the septin family of GTP-binding proteins that form hetero-oligomeric complexes essential for cytoskeletal organization and membrane dynamics. In [neurons](/entities/neurons), septins are critically involved in maintaining synaptic structure, vesicle trafficking, and neuronal polarity. SEPTIN2 dysfunction has been implicated in several neurodegenerative diseases, particularly Parkinson's disease, where altered expression and pathological accumulation have been observed in affected brain regions. Research suggests that septin dysfunction may represent a common mechanism in neurodegeneration, making SEPTIN2 both a potential biomarker and therapeutic target. [@geneprotein]
The SEPTIN2 protein exhibits the characteristic septin architecture consisting of several distinct domains. The N-terminal polybasic region is a highly charged segment that mediates membrane association and phosphoinositide binding, allowing SEPTIN2 to sense and respond to membrane lipid composition. The central GTP-binding domain (G domain) spans approximately 300 amino acids and contains the conserved switch I and II regions that undergo conformational changes during GTP hydrolysis, enabling septins to act as molecular switches. A unique feature of septins is the septin unique element (SUE), a approximately 45 amino acid insertion that is specific to this protein family and contributes to septin-specific functions. The C-terminal coiled-coil domain facilitates homomeric and heteromeric interactions with other septin family members, enabling the formation of diverse oligomeric complexes. SEPTIN2 can form hexameric or octameric rods that further assemble into higher-order structures including filaments, rings, and palisades, which are essential for its biological functions. [@geneprotein]
In the healthy nervous system, SEPTIN2 plays essential roles in maintaining cellular architecture and neuronal communication through multiple coordinated mechanisms.
SEPTIN2 forms heterooligomeric complexes with other septin family members including SEPTIN3, SEPTIN5, SEPTIN6, and SEPTIN7, creating a diverse repertoire of septin assemblies that can respond to different cellular requirements. These complexes create diffusion barriers at the axon initial segment (AIS), which serves as a selective gate controlling protein and organelle trafficking between somatodendritic and axonal compartments. This compartmentalization is critical for maintaining neuronal polarity, as it prevents the mixing of membrane components and signaling molecules that would otherwise diffuse freely along the axon. The septin-based barrier at the AIS thus ensures that the distinct molecular identity of axonal and somatodendritic domains is preserved, supporting proper neuronal polarity and function.
At synaptic sites, SEPTIN2 performs crucial roles in both presynaptic and postsynaptic compartments. In presynaptic terminals, SEPTIN2 localizes to regions involved in synaptic vesicle trafficking and regulates vesicle clustering and release, influencing neurotransmitter release probability and synaptic efficacy. The postsynaptic density also contains SEPTIN2, where it contributes to organizing the complex protein machinery required for receptor trafficking and synaptic signaling. Through these combined pre- and postsynaptic functions, SEPTIN2 helps maintain the structural integrity and functional plasticity of synapses throughout the nervous system.
SEPTIN2 associates with plasma membrane microdomains where it regulates exocytosis and endocytosis pathways, influencing how cells internalize and release molecules. In dendritic spines, SEPTIN2 contributes to morphological maintenance and plasticity, processes that are fundamental to synaptic strength and learning. These membrane-related functions connect SEPTIN2 to the broader cellular machinery that controls neuronal communication and adaptation.
During neural development, SEPTIN2 participates in cytokinesis of neural progenitor cells, ensuring proper cell division and adequate neuron numbers. This developmental function highlights the importance of septin-mediated membrane organization for building a functional nervous system.
SEPTIN2 dysfunction is implicated in several neurodegenerative disorders, where its normal functions are disrupted through various molecular mechanisms.
In Parkinson's disease, SEPTIN2 is downregulated in the substantia nigra, a brain region that undergoes progressive degeneration in PD patients. SEPTIN2 colocalizes with Lewy bodies, the pathological aggregates composed primarily of [alpha-synuclein](/proteins/alpha-synuclein) that characterize PD, suggesting that septin dysfunction may be intimately connected to alpha-synuclein pathology. Genetic variants in SEPTIN2 have been associated with increased PD risk in several population studies. Additionally, SEPTIN2 participates in mitochondrial quality control through its interaction with PARKIN, an E3 ubiquitin ligase mutated in familial forms of PD, linking septin dysfunction to one of the key cellular pathways implicated in PD pathogenesis.
Alzheimer's disease brains show altered septin expression patterns, with SEPTIN2 accumulating in amyloid plaques and colocalizing with other pathological hallmarks. Research suggests that SEPTIN2 may play a role in [tau](/proteins/tau) pathology, potentially intersecting with the two major pathological cascades in AD. Septin dysfunction likely contributes to the synaptic loss that correlates most strongly with cognitive decline in AD, making it a relevant target for understanding disease progression.
In Huntington's disease, mutant [huntingtin](/proteins/huntingtin) directly affects septin assembly, disrupting the normal oligomerization and higher-order structure formation of SEPTIN2 and its partners. Studies in HD models have documented dysregulation of SEPTIN2 expression and localization, which may contribute to the transcriptional alterations that characterize this disorder. This connection between mutant huntingtin and septin dysfunction may help explain some of the broader cellular pathology observed in HD.
SEPTIN2 aggregates have been found in ALS motor neurons, where they may represent a pathological signature of the disease. SEPTIN2 shows interactions with [TDP-43](/mechanisms/tdp-43-proteinopathy), a major pathological protein in ALS, suggesting that septin dysfunction may be part of the cascade leading to motor neuron degeneration. Altered membrane trafficking in ALS may also involve SEPTIN2 dysfunction, connecting septin pathology to the impaired axonal transport observed in this disease.
SEPTIN2 variants have been associated with seizure disorders in genetic studies, indicating that septin dysfunction can predispose to hyperexcitability. Dysregulated vesicle release in epileptic neurons may involve SEPTIN2, potentially linking synaptic dysfunction to seizure generation. These findings suggest that septins may play a broader role in controlling neuronal excitability beyond their established roles in polarity and transport.
SEPTIN2 is implicated in vascular remodeling and aortic integrity, with septin deficiency leading to aortic aneurysms in model systems. [@auto_38357802] The protein also regulates endothelial cell invasion and angiogenesis, processes critical for blood vessel formation and maintenance. [@auto_31865373] These findings expand the physiological roles of SEPTIN2 beyond the nervous system and highlight its importance in maintaining vascular homeostasis.
SEPTIN2 suppresses IFN-γ-independent proinflammatory macrophage activation, indicating that septins play roles in immune regulation. [@auto_37978190] This function may be relevant to the neuroinflammatory component of various neurodegenerative conditions, suggesting potential connections between septin dysfunction and immune-mediated pathology.
Research into SEPTIN2 as a therapeutic target has yielded several promising approaches targeting different aspects of septin biology.
Compounds that promote proper septin polymerization represent one strategy for restoring normal septin function in disease states. Alternatively, GTPase activity modulators can target the conserved GTP-binding function of SEPTIN2, potentially altering its ability to act as a molecular switch. The development of such small molecules requires careful consideration of which septin functions to modulate and in what disease context such intervention would be most beneficial.
AAV-mediated SEPTIN2 overexpression can restore function in models where septin levels are reduced, a strategy particularly relevant for conditions like Parkinson's disease where SEPTIN2 is downregulated. CRISPR approaches offer the possibility of correcting pathogenic variants that may predispose to neurodegenerative disease. For gain-of-function scenarios, siRNA approaches could reduce pathogenic septin levels, providing a flexible toolkit for addressing different molecular mechanisms of septin dysfunction.
Recombinant septin complexes could potentially be used for replacement therapy, delivering functional septin units directly to affected cells. Cell-penetrating peptides targeting septin interactions offer another strategy for modulating septin function at the protein level, potentially interfering with pathological interactions or stabilizing beneficial ones.
SEPTIN2 interacts with key neuronal proteins through specific molecular interfaces that mediate its diverse cellular functions. SEPTIN2 forms heterooligomers with SEPTIN5 in presynaptic terminals, contributing to the presynaptic septin scaffold that regulates vesicle release. SEPTIN7 is critical for higher-order assembly of SEPTIN2 into filaments and higher structures, serving as an essential partner for septin polymerization. SEPTIN6 is a component of neuronal septin complexes, participating in the diverse oligomeric assemblies required for different septin functions. Ankyrin-G maintains the axon initial segment barrier, and SEPTIN2 likely interacts with this scaffold to maintain proper compartmentalization. SNAP25 regulates synaptic vesicle release, and SEPTIN2 may coordinate with this SNARE protein to organize the presynaptic release machinery. PARKIN mediates mitochondrial quality control, and SEPTIN2 participates in this pathway, potentially serving as a scaffold or regulatory component. Alpha-synuclein, the PD-related protein, interacts with SEPTIN2, suggesting that the pathological aggregation of alpha-synuclein may directly affect septin function.